The Native Antigen Company introduces custom contract service for influenza researchers
The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, has introduced its custom contract service to rapidly develop antigen panels for influenza A and B viruses. This new service offers scientists access […]
